$0.4013
-0.0242-5.69%
Últ. Act.: Nov 6, 6:03 PM
Akebia Therapeutics (AKBA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $-0.05 | $-0.03 | -66.7 % |
| Q2 | Aug 5, 2026 | $-0.03 | $-0.03 | 0.00 % |
| Q1 | May 7, 2026 | $-0.03 | $-0.01 | -200.0 % |
| Q4 | Feb 26, 2026 | $-0.05 | $-0.05 | 0.00 % |
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.03 | $-0.03 | $-0.01 | $-0.05 |
| Actual | $-0.05 | $-0.03 | $-0.03 | $-0.05 |
| Surprise | -66.7% | 0.00% | -200.0% | 0.00% |
| Revenue | ||||
| Estimate | $46.9M | $49.5M | $52.6M | $47.9M |
| Actual | $36.9M | $49.1M | $53.5M | $57.6M |
| Surprise | -21.4% | -0.79% | +1.74% | +20.3% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.03 | $-0.09 | $-0.09 | $-0.08 |
| Revenue | ||||
| Consensus | $48.1M | $28.9M | — | — |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $36.90M | $46.93M | -21.4 % |
| Q2 | Aug 5, 2026 | $49.13M | $49.52M | -0.79 % |
| Q1 | May 7, 2026 | $53.54M | $52.63M | 1.74 % |
| Q4 | Feb 26, 2026 | $57.62M | $47.89M | 20.3 % |